Overview

• Health Secretary David Kershenobich said the BCG manufacturer’s relocation of its production plant in India triggered a two-month global delay affecting Mexico’s supply.
• Cofepris currently holds 3.4 million BCG doses pending a new sanitary registration required after the change in manufacturing site.
• Officials estimate the regulatory review will conclude in about four weeks, unlocking enough vaccines for nationwide distribution to clinics and hospitals.
• Authorities stress that infants face no immediate risk since the BCG shot can be administered from birth up to four years and the stockpile covers roughly two years of immunization.
• Some parents have purchased BCG doses in private hospitals for 3,000–8,000 pesos per shot, underscoring concerns over equitable access.